MetaVia Inc reports results for the quarter ended June 30 - Earnings Summary

• MetaVia Inc MTVA.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.85. The mean expectation of four analysts for the quarter was for a loss of 31 cents per share. Wall Street expected results to range from -57 cents to -13 cents per share.

• Reported revenue was zero​; analysts expected zero.

• MetaVia Inc's reported EPS for the quarter was a loss of 26 cents​.

• The company reported a quarterly loss of $4 million.

• MetaVia Inc shares had fallen by 0.7% this quarter and lost 68.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 35% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for MetaVia Inc is $15.50, about 95.9% above its last closing price of $0.64

This summary was machine generated from LSEG data August 12 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)